已发表论文

基于衰老相关基因特征的乳腺癌风险分层和预后预测模型

 

Authors Yuan J, Duan F , Zhai W, Song C, Wang L, Xia W, Hua X , Yuan Z, Bi X, Huang J

Received 19 August 2021

Accepted for publication 24 October 2021

Published 3 November 2021 Volume 2021:13 Pages 1053—1064

DOI https://doi.org/10.2147/IJWH.S334756

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Everett Magann

Background: Aging, an inevitable process characterized by functional decline over time, is a significant risk factor for various tumors. However, little is known about aging-related genes (ARGs) in breast cancer (BC). We aimed to explore the potential prognostic role of ARGs and to develop an ARG-based prognosis signature for BC.
Methods: RNA-sequencing expression profiles and corresponding clinicopathological data of female patients with BC were obtained from public databases in The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). An ARG-based risk signature was constructed in the TCGA cohort based on results of least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analysis, and its prognostic value was further validated in the GSE20685 cohort.
Results: A six ARG-based signature, including CLU, DGAT1, MXI1, NFKBI, PIK3CA  and PLAU , was developed in the TCGA cohort and significantly stratified patients into low- and high-risk groups. Patients in the former group showed significantly better prognosis than those in the latter. Multivariate Cox regression analysis demonstrated that the ARG risk score was an independent prognostic factor for BC. A predictive nomogram integrating the ARG risk score and three identified factors (age, N- and M-classification) was established in the TCGA cohort and validated in the GSE20685 cohort. Calibration plots showed good consistency between predicted survival probabilities and actual observations.
Conclusion: A novel ARG-based risk signature was developed for patients with BC, which can be used for individual prognosis prediction and promoting personalized treatment.
Keywords: breast cancer, aging, prognostic signature, risk stratification